Lung cancer 'Mini-Tumors' grown in lab to predict best therapy
NCT ID NCT03655015
First seen Apr 15, 2026 · Last updated Jun 11, 2026 · Updated 10 times
Summary
This study creates a living collection of miniature lung cancer models (organoids) from 150 patients with stage I-III lung cancer. Researchers will test how these organoids respond to chemotherapy and targeted drugs, comparing results to how patients actually respond. The goal is to improve personalized treatment by predicting which therapies work best for each individual.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UT Health San Antonio, M.D. Anderson Cancer Center
RECRUITINGSan Antonio, Texas, 78229, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.